2026 NPPES data Ophthalmic Plastic and Reconstructive Surgery Physician NPI 1215931670 M.D.
Verify on CMS →

PETER WONG, M.D.

Ophthalmic Plastic and Reconstructive Surgery Physician in ROCKVILLE CENTRE, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 656 beneficiaries · Ophthalmic Plastic and Reconstructive Surgery Physician avg: 624
Generic prescribing
92%
generic claims · 8% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$1.0K
41 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

PETER WONG, M.D. filed 1,796 Medicare Part D claims in 2023 as a Ophthalmic Plastic and Reconstructive Surgery Physician in ROCKVILLE CENTRE, New York, prescribing 92% generic.

2K
Part D claims, 2023
92%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

PETER WONG, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

1,796 Top 17% higher than 83% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). This entry sits in this band. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

PETER WONG, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about PETER WONG, M.D.?

Quality data not reported

NPI registry status

Active

Issued 06/13/2005

NPI 1215931670

Primary specialty

Ophthalmic Plastic and Reconstructive Surgery Physician

Rare

291 US NPIs in this specialty

Medicare Part D claims

1,796 188% vs specialty avg

2023 prescription claims

Specialty avg: 624

Specialty distribution in New York

How Ophthalmic Plastic and Reconstructive Surgery Physician compares to other specialties among New York providers

New York providers

Ophthalmic Plastic and Reconstructive Surgery Physician share within New York

1. Ophthalmic Plastic and Reconstructive Surgery Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Ophthalmic Plastic and Reconstructive Surgery Physician share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Ophthalmic Plastic and Reconstructive Surgery Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Ophthalmic Plastic and Reconstructive Surgery Physician ABMS/AOA estimate

Est. board-certified rate (Ophthalmic Plastic and Reconstructive Surgery Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Ophthalmic Plastic and Reconstructive Surgery Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

PETER WONG, M.D. is a Ophthalmic Plastic and Reconstructive Surgery Physician provider practicing in ROCKVILLE CENTRE, New York, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1215931670. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

PETER WONG, M.D. appears in the CMS NPPES registry as a Ophthalmic Plastic and Reconstructive Surgery Physician provider holding M.D. credentials at 2000 N VILLAGE AVE, ROCKVILLE CENTRE, NY, 11570, with a listed phone of (516) 766-2519. NPI 1215931670 was issued on 06/13/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what WONG most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,796 prescription claims written by this provider, covering 656 Medicare beneficiaries and totaling roughly $685K in drug spend, split 8% brand-name and 92% generic by claim count, with an opioid prescribing rate of 23.4%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Ophthalmic Plastic and Reconstructive Surgery Physician is a narrow specialty nationwide, with 291 enrolled providers across 46 states and an average of 624 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2000 N VILLAGE AVE
ROCKVILLE CENTRE, NY 11570

Provider Details

NPI 1215931670
Specialty Ophthalmic Plastic and Reconstructive Surgery Physician
Credentials M.D.
Gender Male
NPI Issued 06/13/2005

Hospital and facility affiliations

Facilities where PETER WONG, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

OPHTHALMIC CONSULTANTS OF LONG ISLAND
ROCKVILLE CENTRE, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for PETER WONG, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$1.0K

Largest payer

ABBVIE INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to PETER WONG, M.D.. To verify PETER WONG, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

PETER WONG, M.D. — brand share 8.0%
Specialty average (est.)

8% brand-name claims vs 92% generic, on 1,796 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,796
Total Claims
$685K
Total Drug Cost
656
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,860
Total Day Supply
20,913
Brand vs Generic
8% brand / 92% generic
Brand Drug Cost
$661K
Generic Drug Cost
$24K
Opioid Claims
420 (23.4% rate)
Antibiotic Claims
190

Patient Demographics

Average Patient Age
74.2 years
Avg HCC Risk Score
1.09
Gender Split
67% female / 33% male
Age Distribution
<65: 39, 65-74: 316, 75-84: 223, 85+: 78

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Erythromycin
Erythromycin Base
641
Acetaminophen-Codeine
Acetaminophen With Codeine
382
Tobramycin-Dexamethasone
Tobramycin/Dexamethasone
150
Doxycycline Hyclate
104
Tobramycin
82
Cephalexin
77
Methylprednisolone
74
Azasite
Azithromycin
38
Neomycin-Polymyxin-Dexameth
Neomycin/Polymyxin B/Dexametha
30
Bepotastine Besilate
24

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Ophthalmic Plastic and Reconstructive Surgery Physician Overview

How PETER WONG, M.D. fits within the Ophthalmic Plastic and Reconstructive Surgery Physician landscape nationally.

291
Ophthalmic Plastic and Reconstructive Surgery Physician Providers in US
46
States with Ophthalmic Plastic and Reconstructive Surgery Physician
624
Avg Claims per Provider

PETER WONG, M.D.'s 1,796 claims are above the specialty average of 624.

Nearby Ophthalmic Plastic and Reconstructive Surgery Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as WONG.

Compare Ophthalmic Plastic and Reconstructive Surgery Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is PETER WONG, M.D.'s specialty?
PETER WONG, M.D. specializes in Ophthalmic Plastic and Reconstructive Surgery Physician and practices in ROCKVILLE CENTRE, New York. Credentials: M.D..
How much does PETER WONG, M.D. prescribe under Medicare Part D?
In 2023, PETER WONG, M.D. wrote 1,796 Medicare Part D claims totaling $685K in drug costs for 656 beneficiaries.
Where is PETER WONG, M.D. located?
PETER WONG, M.D. is located at 2000 N VILLAGE AVE, ROCKVILLE CENTRE, NY, 11570. Phone: (516) 766-2519.
What is PETER WONG, M.D.'s NPI number?
PETER WONG, M.D.'s National Provider Identifier (NPI) is 1215931670, issued on 06/13/2005.
Does PETER WONG, M.D. prescribe more brand-name or generic drugs?
PETER WONG, M.D.'s prescribing is 8% brand-name and 92% generic drugs by claim count, with $661K in brand drug costs.
Does PETER WONG, M.D. prescribe opioids?
Yes, PETER WONG, M.D. had 420 opioid claims in 2023 with an opioid prescribing rate of 23.4%.
How many Ophthalmic Plastic and Reconstructive Surgery Physician providers are there in the US?
There are 291 Ophthalmic Plastic and Reconstructive Surgery Physician providers across 46 states in the US. The average Ophthalmic Plastic and Reconstructive Surgery Physician provider writes 624 Medicare Part D claims per year.
What drugs does PETER WONG, M.D. prescribe most often?
Based on 2023 Medicare Part D data, PETER WONG, M.D.'s most frequently prescribed drugs include Erythromycin, Acetaminophen-Codeine, Tobramycin-Dexamethasone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does PETER WONG, M.D. accept Medicare?
PETER WONG, M.D. appears in CMS Medicare data with 1,796 Part D claims and 656 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify PETER WONG, M.D.'s credentials?
PETER WONG, M.D.'s NPI is 1215931670 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology